Abcuro
Drug DiscoveryWebsite
Developer of immunomodulatory therapeutics designed for treating both autoimmunity and cancer. The company uses proprietary analysis of transcription data from human disease to identify new approaches...
Valuation
$700M
Market implied
Share Price
N/A
Total Raised
$407.3M
Last Round
Later Stage VC (Series C)
Feb 2025
Latest Funding Round
Later Stage VC (Series C)
Feb 7, 2025
$200M
raised
Investors
+20 other investors